EU ingredient rules · 1 min read

Commiphora Erythrea Glabrescens Gum Oil in cosmetics: EU rules

Quick answer: Commiphora Erythrea Glabrescens Gum Oil is a restricted cosmetic ingredient in the EU: Annex III (entry 183) allows it only within set limits, at up to 0.6% in the ready-to-use product. CosIng lists its functions as perfuming.

Key facts

Commiphora Erythrea Glabrescens Gum Oil at a glance
INCI nameCOMMIPHORA ERYTHREA GLABRESCENS GUM OIL
CAS number93686-00-1 / 100084-96-6
EC number297-649-7 / 309-134-7
EU statusRestricted (Annex III, entry 183)
Functions (CosIng)Perfuming

CosIng description: "Opoponax Oil". Commiphora Erythrea Glabrescens Gum Oil is an essential oil distilled from the gum exudate of the Commiphora erythrea var. glabrescens, Burseraceae

What it does in a product

  • Perfuming: Used to add scent, and listed in CosIng under a perfuming name.

Annex III: restricted substances, entry 183

Annex III lists substances that cosmetics may contain only within the limits set there, such as a maximum concentration, the product types they may be used in, and warnings that must appear on the label.

The entry is listed as Commiphora erythrea engler var. glabrescens engler gum extract and oil

Maximum concentration in the ready-to-use product: 0.6%

Most recent legal act listed by CosIng for this entry: Regulation (EC) 2013/344.

Scientific Committee on Consumer Safety (SCCS) opinions:

Why it matters for shelf life

The EU rules above cover what may go into a product, not how long it lasts. For that, follow the period after opening (the open-jar symbol) or the date printed on the pack, and stop using anything that has changed in smell, color or texture.

Not sure how to read a label? What an INCI name is · How ingredient lists work

Source

European Commission, CosIng (Cosmetic Ingredients database), entries for COMMIPHORA ERYTHREA GLABRESCENS GUM OIL and Annex III/183, retrieved 2026-10-11. CosIng is provided for information only and has no legal value; the legally binding text is Regulation (EC) No 1223/2009 and its amendments as published in the Official Journal of the European Union. Rules outside the EU, for example in the US, can differ. This page is not legal or medical advice.